Profil
Ira Weisberg is currently President-Medical Division at Endonovo Therapeutics, Inc. since 2022.
Former positions include President & Chief Executive Officer at AlphaVax, Inc., Amherst Pharmaceuticals LLC, and SofPulse, Inc.; Senior Director-Business Development at Aventis Behring; Senior Vice President-Commercial Operations at Neurotrope, Inc.; Vice President-Commercial Operations at TAO Synergies, Inc.; and Vice President-Operations at Haemacure Corp.
(Florida).
Education includes undergraduate studies at St. John's University.
Aktive Positionen von Ira Weisberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 30.11.2022 |
Ehemalige bekannte Positionen von Ira Weisberg
| Unternehmen | Position | Ende |
|---|---|---|
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | 29.11.2011 |
Haemacure Corp. (Florida) | Geschäftsführer | - |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | - |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Vorstandsvorsitzender | - |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Vorstandsvorsitzender | - |
Ausbildung von Ira Weisberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Neurotrope, Inc.
Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops off the shelf regenerative products that no longer require the injection of stem cells | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Health Technology |
Haemacure Corp. (Florida) | |
Synaptogenix, Inc.
Synaptogenix, Inc. Packaged SoftwareTechnology Services Develops decentralized blockchain network that focuses on convergence between cryptocurrency and artificial intelligence | Technology Services |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
















